Tiny biotech takes on Glaxo’s $730000 gene therapy – San Francisco Chronicle
San Francisco Chronicle |
Tiny biotech takes on Glaxo's $730000 gene therapy
San Francisco Chronicle Orchard, whose team includes three former Glaxo executives, wants to one-up the larger company by taking aim at a Strimvelis shortcoming. While Glaxo's therapy can't be transported, Orchard is planning to use frozen cells that can travel to markets all … |
